肝细胞特异性期MRI对良性肝细胞肿瘤的表征:同相位成像及病灶与肝视觉信号强度比的附加价值
该研究回顾性分析经组织学证实的29个局灶性结节性增生(FNH)和33个肝细胞腺瘤(HCA),评估钆贝葡胺增强肝胆期MRI上病灶与肝视觉信号强度比(SIR)及不同T1加权序列的诊断价值。结果显示同相位T1WI特异性显著高于反相位和脂肪抑制序列,且比较增强前后SIR变化可准确分类良性肝细胞病变,避免活检。
要点
- 同相位T1WI应系统纳入肝胆期MRI方案,因在脂肪肝时最可靠。
- 比较增强前后病灶与肝SIR可无错分地将良性肝细胞病变分为FNH(SIR升高)、HCA(SIR降低)和不确定病变(SIR稳定)。
- 同相位T1WI诊断FNH的特异性显著高于反相位(P=0.015)和脂肪抑制序列(P=0.042)。
核心结论
- 同相位T1WI是最可靠的序列,因使用脂肪抑制或反相位序列时脂肪肝会导致误导性肿瘤/肝信号比;增强前后病灶与肝SIR可准确分类良性肝细胞病变并有助于避免活检。
研究设计与样本
- 回顾性识别2009至2017年经组织学证实为FNH和HCA且接受钆贝葡胺增强肝胆期MRI的患者,由两名放射科医生在肝胆期及增强前后于同相位、反相位和脂肪抑制T1WI上视觉评估病灶与肝SIR。
关键影像表现/征象
- 肝胆期分析中,FNH在所有T1WI上呈高信号或等信号者占89.7%。
- HCA在同相位、反相位和脂肪抑制T1WI上呈低信号者分别占93.9%、63.6%和69.7%。
- 增强前后分析中,FNH的SIR升高者占55.2-58.6%、稳定者占44.8-58.6%、降低者占0%,而HCA的SIR降低者占66.7-93.9%、稳定者占6.1-33.3%、升高者占0%(P<0.0001)。
诊断标准与关键数值
- 肝胆期分析中,FNH以高信号或等信号为特征(占89.7%),HCA以低信号为特征(同相位93.9%、反相位63.6%、脂肪抑制69.7%)。
- 增强前后SIR变化分类:FNH表现为SIR升高(55.2-58.6%)或稳定(44.8-58.6%),HCA表现为SIR降低(66.7-93.9%)或稳定(6.1-33.3%),不确定病变表现为SIR稳定。
- 同相位T1WI诊断FNH的特异性显著高于反相位(P=0.015)和脂肪抑制序列(P=0.042)。
临床应用与阅片要点
- 同相位T1WI应系统纳入肝胆期MRI方案,因在脂肪肝时最可靠。
- 比较增强前后病灶与肝SIR有助于将良性肝细胞病变分类为FNH、HCA或不确定病变,并避免活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the lesion-to-liver visual signal intensity ratio (SIR) before and at the hepatobiliary phase MRI (HBP-MRI) after gadobenate dimeglumine (Gd-BOPTA) injection, using several T1-weighted images (T1-WI), for the characterization of benign hepatocellular lesions.
METHODS: Patients with histologically proven focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA), who underwent Gd-BOPTA-enhanced HBP-MRI from 2009 to 2017, were retrospectively identified. The lesion-to-liver SIR was visually assessed by two radiologists on HBP (post-HBP analysis) and compared with that of unenhanced sequences (pre/post-HBP analysis) on T1-WI in-phase (T1-IP), out-of-phase (T1-OP), and fat suppression (T1-FS). Lesions were classified as hyper-, iso-, or hypointense on post-HBP, and as decreasing, stable, or increasing SIR on pre/post-HBP analyses. The performance of the different T1-WI sequences for the diagnostic of FNH was evaluated on post-HBP analysis.
RESULTS: Twenty-nine FNHs and 33 HCAs were analyzed. On post-HBP analysis, FNHs appeared hyper-/isointense in 89.7% of all T1-WI. HCAs appeared hypointense in 93.9%, 63.6%, and 69.7% of T1-IP, T1-OP, and T1-FS, respectively. FNHs exhibited an increasing SIR in 55.2-58.6%, a stable SIR in 44.8-58.6%, and a decreasing SIR in 0%, whereas HCAs exhibited a decreasing SIR in 66.7-93.9%, a stable SIR in 6.1-33.3%, and an increasing SIR in 0% (p < 0.0001). The specificity of T1-IP was significantly higher than that of T1-OP (p = 0.015) and T1-FS (p = 0.042).
CONCLUSION: T1-IP is the most reliable sequence due to misleading tumor/liver signal ratio in the case of fatty liver when using T1-FS or T1-OP. The pre/post-HBP lesion-to-liver SIR is accurate to classify benign hepatocellular lesions and contributes to avoid biopsy.
KEY POINTS: •The T1-weighted images in-phase should be systematically included in the HBP-MRI protocol, as it is the most reliable sequence especially in the case of fatty liver. •The comparison between lesion-to-liver signal intensity ratios on unenhanced and at the hepatobiliary phase sequences is useful to classify benign hepatocellular lesions in three categories without misclassification: FNH (increasing signal intensity ratio), HCA (decreasing signal intensity ration), and indeterminate lesions (stable signal intensity ratio).
引用
- Lebert P, Adens-Fauquembergue M, Azahaf M, et al. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio. Eur Radiol. 2019. PMID: 30993437. doi:10.1007/s00330-019-06210-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。